Planta Med 2017; 83(14/15): 1176-1183
DOI: 10.1055/s-0043-109002
Biological and Pharmacological Activity
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Saffron Flower Extract Promotes Scratch Wound Closure of Keratinocytes and Enhances VEGF Production[*]

Sheela Verjee
1   Institute for Pharma Technology, School of Life Sciences, University of Applied Sciences Northwestern Switzerland, Muttenz, Switzerland
,
Eliane Garo
2   Institute of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
,
Sarah Pelaez
1   Institute for Pharma Technology, School of Life Sciences, University of Applied Sciences Northwestern Switzerland, Muttenz, Switzerland
,
Orlando Fertig
2   Institute of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
,
Matthias Hamburger
2   Institute of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
,
Veronika Butterweck
1   Institute for Pharma Technology, School of Life Sciences, University of Applied Sciences Northwestern Switzerland, Muttenz, Switzerland
› Author Affiliations
Further Information

Publication History

received 23 January 2017
revised 25 March 2017

accepted 06 April 2017

Publication Date:
20 April 2017 (online)

Abstract

During saffron (Crocus sativus) spice production, large amounts of floral biowaste are generated. It was the aim of this study to develop a value-added product from saffron floral biowaste to be used as a natural cosmetic ingredient. HPLC-PDA-MS analysis of saffron flower extracts revealed the presence of flavonols with the highest amounts in the acetone extract. Kaempferol-3-O-sophoroside was identified as the main flavonoid in the acetone extract (saffron flower acetone extract). Saffron flower acetone extract and kaempferol-3-O-sophoroside were tested in HaCaT cells for potential effects on cell migration, proliferation, and for anti-inflammatory properties. Saffron flower acetone extract concentration dependently (50–200 µg/mL) augmented cell proliferation, as indicated by an increased BrdU-incorporation, while kaempferol-3-O-sophoroside (1–50 µM) had no effect. Furthermore, treatment of HaCaT cells with saffron flower acetone extract, but not with kaempferol-3-O-sophoroside, concentration-dependently increased vascular endothelial growth factor secretion (control 49.72 pg/mL vs. saffron flower acetone extract at 200 µg/mL 218.60 pg/mL). Cell migration was determined using time-lapse microscopy and a modification of the scratch-wound assay in which saffron flower acetone extract significantly improved wound closure compared to the untreated control. Overproduction of the proinflammatory cytokines interleukin-8 and interleukin-6 in HaCaT cells was induced by TNF-α. Kaempferol-3-O-sophoroside (10–50 µM), but not saffron flower acetone extract, inhibited TNF-α-induced IL-8 secretion. The effect was comparable to 10 µM hydrocortisone (positive control). Interestingly, saffron flower acetone extract further increased IL-6 levels in TNF-α-treated HaCaT cells in a concentration-dependent manner. In summary, the pronounced wound healing properties of saffron flower acetone extract present a promising application for the cosmetic industry.

* Dedicated to Professor Dr. Max Wichtl in recognition of his outstanding contribution to pharmacognosy research.


Supporting Information

 
  • References

  • 1 Laufenberg G, Kunz B, Nystroem M. Transformation of vegetable waste into value added products: (A) the upgrading concept; (B) practical implementations. Bioresour Technol 2003; 87: 167-198
  • 2 Federici F, Fava F, Kalogerakis N, Mantzavinos D. Valorisation of agro-industrial by-products, effluents and waste: concept, opportunities and the case of olive mill watsewaters. J Chem Technol Biotechnol 2009; 84: 895-900
  • 3 Fernández J-A, Pandalai S. Biology, biotechnology and biomedicine of saffron. Recent Res Devel Plant Sci 2004; 2: 127-159
  • 4 Serrano-Diaz J, Sanchez AM, Maggi L, Martinez-Tome M, Garcia-Diz L, Murcia MA, Alonso GL. Increasing the applications of Crocus sativus flowers as natural antioxidants. J Food Sci 2012; 77: C1162-C1168
  • 5 Montoro P, Maldini M, Luciani L, Tuberoso CIG, Congiu F, Pizza C. Radical scavenging activity and LC-MS metabolic profiling of petals, stamens, and flowers of Crocus sativus L. J Food Sci 2012; 77: C893-C900
  • 6 Montoro P, Tuberoso CIG, Maldini M, Cabras P, Pizza C. Qualitative profile and quantitative determination of flavonoids from Crocus sativus L. Petals by LC-MS/MS. Nat Prod Commun 2008; 3: 2013-2016
  • 7 Norbaek R, Brandt K, Nielsen JK, Orgaard M, Jacobsen N. Flower pigment composition of Crocus species and cultivars used for a chemotaxonomic investigation. Biochem Syst Ecol 2002; 30: 763-791
  • 8 Serrano-Diaz J, Sanchez AM, Martinez-Tome M, Winterhalter P, Aonso GL. Flavonoid determination in the quality control of floral bioresidues from Crocus sativus L. J Agr Food Chem 2014; 62: 3125-3133
  • 9 Termentzi A, Kokkalou E. LC-DAD-MS (ESI(+)) analysis and antioxidant capacity of Crocus sativus petal extracts. Planta Med 2008; 74: 573-581
  • 10 Goupy P, Vian MA, Chemat F, Caris-Veyrat C. Identification and quantification of flavonols, anthocyanins and lutein diesters in tepals of Crocus sativus by ultra performance liquid chromatography coupled to diode array and ion trap mass spectrometry detections. Ind Crop Prod 2013; 44: 496-510
  • 11 Kubo I, Kinst-Hori I. Flavonols from saffron flower: tyrosinase inhibitory activity and inhibition mechanism. J Agr Food Chem 1999; 47: 4121-4125
  • 12 Li CY, Lee EJ, Wu TS. Antityrosinase principles and constituents of the petals of Crocus sativus . J Nat Prod 2004; 67: 437-440
  • 13 Fatehi M, Rashidabady T, Fatehi-Hassanabad Z. Effects of Crocus sativus petalsʼ extract on rat blood pressure and on responses induced by electrical field stimulation in the rat isolated vas deferens and guinea-pig ileum. J Ethnopharmacol 2003; 84: 199-203
  • 14 Moshiri E, Basti AA, Noorbala AA, Jamshidi AH, Abbasi SH, Akhondzadeh S. Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial. Phytomedicine 2006; 13: 607-611
  • 15 Hosseinzadeh H, Younesi HM. Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice. BMC Pharmacol 2002; 2: 7
  • 16 Vissiennon C, Nieber K, Kelber O, Butterweck V. Route of administration determines the anxiolytic activity of the flavonols kaempferol, quercetin and myricetin – are they prodrugs?. J Nutr Biochem 2012; 23: 733-740
  • 17 Khorasani G, Hosseinimehr SJ, Zamani P, Ghasemi M, Ahmadi A. The effect of saffron (Crocus sativus) extract for healing of second-degree burn wounds in rats. Keio J Med 2008; 57: 190-195
  • 18 Wedler J, Daubitz T, Schlotterbeck G, Butterweck V. In vitro anti-inflammatory and wound-healing potential of a Phyllostachys edulis leaf extract–identification of isoorientin as an active compound. Planta Med 2014; 80: 1678-1684
  • 19 Wedler J, Rusanov K, Atanassov I, Butterweck V. A polyphenol-enriched fraction of rose oil distillation wastewater inhibits cell proliferation, migration and TNF-alpha-induced VEGF secretion in human immortalized keratinocytes. Planta Med 2016; 82: 1000-1008
  • 20 Budzianowski J. Kaempferol glycosides from Hosta ventricosa . Phytochemistry 1990; 29: 3643-3647
  • 21 Takematsu H, Tagami H. Mode of release of interleukin-8 from proliferating human epidermal keratinocytes in vitro . Exp Dermatol 1993; 2: 121-124
  • 22 Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen 2008; 16: 585-601
  • 23 Strodtbeek F. Physiology of wound healing. Newborn Infant Nurs Rev 2001; 1: 43-52
  • 24 Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG, Werner S. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 1995; 270: 12607-12613
  • 25 Wilgus TA, Matthies AM, Radek KA, Dovi JV, Burns AL, Shankar R, DiPietro LA. Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes. Am J Pathol 2005; 167: 1257-1266
  • 26 Rossiter H, Barresi C, Pammer J, Rendl M, Haigh J, Wagner EF, Tschachler E. Loss of vascular endothelial growth factor A activity in murine epidermal keratinocytes delays wound healing and inhibits tumor formation. Cancer Res 2004; 64: 3508-3516
  • 27 Khanna S, Roy S, Bagchi D, Bagchi M, Sen CK. Upregulation of oxidant-induced VEGF expression in cultured keratinocytes by a grape seed proanthocyanidin extract. Free Radical Bio Med 2001; 31: 38-42
  • 28 Nizamutdinova IT, Kim YM, Chung JI, Shin SC, Jeong YK, Seo HG, Lee JH, Chang KC, Kim HJ. Anthocyanins from black soybean seed coats stimulate wound healing in fibroblasts and keratinocytes and prevent inflammation in endothelial cells. Food Chem Toxicol 2009; 47: 2806-2812
  • 29 Mojzis J, Varinska L, Mojzisova G, Kostova I, Mirossay L. Antiangiogenic effects of flavonoids and chalcones. Pharmacol Res 2008; 57: 259-265
  • 30 Banno T, Gazel A, Blumenberg M. Effects of tumor necrosis factor-alpha (TNF alpha) in epidermal keratinocytes revealed using global transcriptional profiling. J Biol Chem 2004; 279: 32633-32642
  • 31 Kupper TS, Min K, Sehgal P, Mizutani H, Birchall N, Ray A, May L. Production of IL-6 by keratinocytes. Implications for epidermal inflammation and immunity. Ann N Y Acad Sci 1989; 557: 454-464
  • 32 Larsen CG, Anderson AO, Oppenheim JJ, Matsushima K. Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor. Immunology 1989; 68: 31-36
  • 33 Singer AJ, Clark RAF. Mechanisms of disease – cutaneous wound healing. N Engl J Med 1999; 341: 738-746
  • 34 Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 2011; 1813: 878-888
  • 35 Hubner G, Werner S. Serum growth factors and proinflammatory cytokines are potent inducers of activin expression in cultured fibroblasts and keratinocytes. Exp Cell Res 1996; 228: 106-113
  • 36 Gallucci RM, Sloan DK, Heck JM, Murray AR, OʼDell SJ. Interleukin 6 indirectly induces keratinocyte migration. J Invest Dermatol 2004; 122: 764-772
  • 37 Sato M, Sawamura D, Ina S, Yaguchi T, Hanada K, Hashimoto I. In vivo introduction of the interleukin 6 gene into human keratinocytes: induction of epidermal proliferation by the fully spliced form of interleukin 6, but not by the alternatively spliced form. Arch Dermatol Res 1999; 291: 400-404
  • 38 Rennekampff HO, Hansbrough JF, Kiessig V, Dore C, Sticherling M, Schroder JM. Bioactive interleukin-8 is expressed in wounds and enhances wound healing. J Surg Res 2000; 93: 41-54
  • 39 Harada A, Sekido N, Akahoshi T, Wada T, Mukaida N, Matsushima K. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol 1994; 56: 559-564
  • 40 Arican O, Aral M, Sasmaz S, Ciragil P. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17 and IL-18 in patients with active psoriasis and correlation with disease severity. Mediat Inflamm 2005; 2005: 273-279
  • 41 Kim TH, Ku SK, Lee IC, Bae JS. Anti-inflammatory effects of kaempferol-3-O-sophoroside in human endothelial cells. Inflamm Res 2012; 61: 217-224
  • 42 Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988; 106: 761-771
  • 43 Park K, Lee JH, Cho HC, Cho SY, Cho JW. Down-regulation of IL-6, IL-8, TNF-alpha and IL-1 beta by glucosamine in HaCaT cells, but not in the presence of TNF-alpha. Oncol Lett 2010; 1: 289-292